Hypertension causes cognitive impairment, involving mainly executive functions, but the effect of blood pressure (BP) control on the different cognitive domains is still debated. We correlated executive function, attention and memory with BP control and cerebrovascular damage in 60 undemented middle-aged hypertensives at baseline and after 6-year follow-up. At first evaluation, the patients with poor BP control had higher score of white matter lesions, reduced cerebrovascular reserve capacity and greater carotid intima-media thickness (IMT) than those with good BP control. Performance on executive tests correlated with IMT and with performance on attention tests, which was impaired by low diastolic BP. At long-term follow-up, performance in attention and executive tests improved in spite of the minor improvement of BP control, increased IMT and worse memory. Low diastolic BP has a negative effect on attention, which affects executive performance at first cross-sectional examination. This confounding effect has to be taken into consideration when planning studies on cognitive function. Longitudinal studies are required to unravel the effect of BP control on cognitive function, as only long-term antihypertensive treatment improves both attention and executive performance.
Introduction
The role of hypertension as a risk factor for cognitive impairment is known from cross-sectional 1 and longitudinal studies. [2] [3] [4] Damage to the brain in hypertension is mediated by changes on the cerebral vasculature affecting both large and small vessels. The macrovascular atherosclerotic disease causes brain infarcts that can be either clinically evident as stroke or silent. The microvascular disease results in chronic ischaemic changes affecting the white matter to a large extent (also known as WMLs, white matter lesions or leukoaraiosis). The outcome of single or multiple events is a stepwise progression to multi-infarct dementia, while the outcome of chronic microvascular damage is a continuous progression from mild cognitive alterations to overt vascular dementia. 5 Vascular lesions have also a permissive effect on the clinical expression of neurodegenerative dementia of the Alzheimer type. 6 A subtype of vascular dementia, the subcortical syndrome, is particularly related to hypertension and to the cardiovascular risk factors and it is characterized by impairment of executive function and attention. 5 The effect of antihypertensive therapy on cognitive decline remains, however, controversial. 7 The inconsistency of the current evidence on the cognitive effect of antihypertensive therapy may stem either from the use of cognitive tests that are insufficiently sensitive and specific to detect slowly progressing cognitive impairment or from discrete effects of blood pressure (BP) on various cognitive domains. 8 Therefore, we assessed the effect of long-term antihypertensive treatment on cognitive decline by means of a comprehensive neuropsychological examination including executive functions, memory and attention and we correlated cognitive outcomes with markers of atherosclerosis and of cerebrovascular vasomotor function.
Patients and methods
The setting was the local outpatient Hypertension Clinic, wherein 60 patients aged 50-80 years, with long-term hypertension were enroled after written informed consent was obtained. Patients with a history of cerebrovascular events, established dementia (defined as Mini-Mental State Examination score o25), epilepsy, severe heart, liver, kidney or respiratory failure, carotid artery stenosis over 65%, major sight impairment or treatment with clonidine, alpha-methyldopa or psychotropic medicaments were excluded. After the first evaluation, the patients were followed with periodical BP check up at the general practise and referral for therapy adjustment in case of poor BP control according to international practise guidelines. 9 After 6 ± 1 years (range 4-8), the patients were recruited for a second evaluation. Three patients refused the second evaluation, one patient was lost to follow-up, four patients were deceased, three patients had developed advanced stage cancer, one severe pulmonary disease, one epilepsy and one severe depression. Therefore, only 46 patients underwent the second evaluation.
The study protocol was approved by the local ethical committee. The study design is described in Figure 1 .
BP measurement BP was measured by a trained clinician in the sitting position, after 10-min rest, with a mercury sphygmomanometer, to the nearest 2 mm Hg. Office BP was recorded as the mean of two measurements at every visit at the Outpatient Clinic before enrolment and at the time of study. At study enrolment, all patients underwent 24-h ambulatory BP monitoring using a SpaceLabs instrument (model 90207, Spacelabs Healthcare, Issaquah, WA, USA). BP was recorded every 15 min during the day and every 20 min during the night. Raw data were processed by dedicated software. Satisfactory BP control was defined as 24-h mean systolic BP (SBP)o125 mm Hg and 24-h mean diastolic BP (DBP)o80 mm Hg according to the European Society of Hypertension-European Society of Cardiology Guidelines. 9 
Neuropsychological assessment
Neuropsychological assessment was performed individually by experienced neuropsychologists using a set of well-validated tests, including the MiniMental State Examination 10 , as well as ''paper and pencil'' and computerized tests designed to extensively investigate different cognitive domains. A detailed description of neuropsychological tests and their clinical meaning is provided elsewhere. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Memory was examined by the 10-s interference memory and scan tests (working memory), digit span test (short-term memory) and logical story test (long-term memory). The executive functions were determined by 30 s interference memory test, trail making test part B, phonemic verbal fluency, scan test and double task paradigm. Attention was examined by trail making test part A and symbol digit substitution test.
Neuropsychological test scores were expressed by age-and education-adjusted z-scores. Scores lower than 1.5 s.d. (zoÀ1.5) were considered to be abnormal. However, the analysis of speed test scores (trail making test part A and B and symbol-digit substitution test) was performed using-(z), as the lowest scores represent the best performance. Target organ damage Cerebrovascular reactivity was estimated from changes in blood flow velocity of the middle cerebral artery 22 recorded with a 2 MHz Doppler instrument (DWL Systems, Singen, Germany). Middle cerebral artery was insonated bilaterally through the temporal window at 45-50-55 mm depth and the best signal was selected for further measurements. After a period of 5 min to allow signal stabilization and recording of baseline values, the patients were administered 13 mg kg -1 body weight intravenous acetazolamide and mean blood flow velocity was measured 5, 10 and 15 min after injection. Cerebrovascular reactivity was calculated at 5-min intervals after acetazolamide administration, as the fractional change of mean flow velocity over baseline values.
Carotid arteries were evaluated with high-resolution ultrasonography (Aspen Advanced, ACUSON, Mountain View, CA, USA). The study protocol included a standard diagnostic examination, followed by measurement of intima-media thickness (IMT), according to the indications of the Mannheim IMT Consensus. 23 The sonographer was blinded to the patient's status. Examinations were recorded on super VHS videotape (Panasonic AG MD830, Jersey City, NJ, USA). Peak-systolic and end-diastolic velocities were determined on a longitudinal scan in the common and internal carotid arteries and at the site of plaques, if present. Stenosis was graded according to the NASCET echographic criteria and Doppler velocimetry. 24 Carotid IMT, defined as the distance between the lumen-intima and the mediaadventitia interfaces, was measured at end-diastole in the far wall of the common carotid artery, bulb and the internal carotid artery with lateral probe incidence. IMT was measured at three segments on either side (common carotid artery: 10 mm proximal to the dilatation of the bulb; bulb; and internal carotid artery: 10 mm distal to the flow divider). Maximum IMT of each segment was measured at the focal greatest thickening. The highest maximum IMT (IMT-max) and the average of IMT measurements taken at internal carotid artery and common carotid artery (IMT-mean) on both sides were used for the statistical analysis.
Forty-two patients accepted to undergo magnetic resonance imaging head scan. All magnetic resonance imaging investigations were performed using the same 1.0 T system. The study protocol included a T1-weighted scan (TR 434 ms, TE 12 ms, field of view 240 mm, matrix 192 Â 256, 1 excitation) with 15 sagittal slices (slice thickness 6 mm, interslice gap 0.5 mm). Axial images were aligned parallel to the bicommissural line, as defined in the midsagittal T1 image. 20 axial slices (thickness 5.5 mm, gap 0.5 mm) were obtained using a fluid attenuated inversion recovery sequence (TR 6000, TI 2100, TE 80, echo train length 8, field of view 240 mm, matrix 192 Â 256, 1 excitation) and then the same positioning was used to obtain 20 diffusion-weighted slices (echoplanar, spin-echo technique, b-value 0 and 1000 along the three perpendicular axes, TR 7000 ms, TE 80, field of view 240 mm, matrix 60 Â 60, thickness 5.5 mm, gap 0.5 mm). Subcortical hyperintensities were graded according to the following reported scale. 25 For the WML the score was: 1, no lesions (including symmetrical, welldefined caps or bands); 2, focal lesions; 3: beginning confluent lesions; 4: diffuse involvement of the entire region, with or without involvement of U fibres. For basal ganglia lesions: 1, no lesions; 2, one focal lesion (X5 mm); 3: more than one focal lesion; 4: confluent lesions.
Statistical analysis
The data are expressed as mean±s.d. The Gaussian fit of each variable was tested by KolmogorovSmirnov test. Comparisons between good BP control and poor BP control group at enrolment were carried out using the independent samples Student's t-test. Paired samples t-test and Pearson's correlation were used for within-patient comparisons between T0 and T1. One-way analysis of variance with linear regression analysis was used for the estimation of outcome predictors. Distribution of dichotomic variables was compared using the w 2 -test. The analysis was performed using SPSS (Statistical Package for Social Sciences, 12.0.2, Chicago, IL, USA). A level of Po0.05 was accepted as statistically significant.
Results

Cross-sectional evaluation at enrolment
The cohort characteristics are listed in Table 1 . Thirty-one patients met the criteria for good BP control according to the European Society of Hypertension-European Society of Cardiology Guidelines (that is, 24-h ambulatory BP o125/ 80 mm Hg), 9 while 29 had poor BP control ( Table 2 ). The patients with worse BP control were more ) n (%) 24 (40) Diabetes n (%) 9 (15) Total cholesterol4200 mg per 100 ml n (%) 37 (62) Triglycerides 4200 mg per 100 ml n (%) 15 ( Twenty-six patients had WMLs on magnetic resonance imaging involving mainly the frontal lobes and 12 also showed basal ganglia lesions. Prevalence of lesions with a total score X1 was higher in the poor BP control group (11/20 vs 2/22, Po0.005). The time course of the change of middle cerebral artery flow velocity after acetazolamide is shown in Figure 2 . All the cerebrovascular damage markers were significantly correlated to BP control status: in the good BP control group, IMT was lower (maximum IMT 0.09 ± 0.03 vs 0.12 ± 0.05 cm, P ¼ 0.001), maximal acetazolamide vasodilatation (cerebrovascular reserve capacity) higher (0.40 ± 0.14 vs 0.32±0.12, Po0.05, Figure 2 ) and total WML score lower (0.73±1.12 vs 1.70±1.42, P ¼ 0.01). IMT and WML score correlated each other (r ¼ 0.329, Po0.05) and with 24-h SBP (r ¼ 0.271, Po0.05, and r ¼ 0.437, Po0.005, respectively).
Prevalence of cognitive impairment (defined as lower than normal performance in one or more tests) was 65% of the whole sample. Attention was impaired in 23%, executive function in 48% and memory in 28% of the whole sample. No significant difference in cognitive performance by BP control status was found (Table 3) . Composite scores for the Table 4 ), showing that low executive function score was predicted by low attention score and by increased IMT, while BP was not a predictor. Models including other risk factors such as age and diabetes were not significant.
Longitudinal study
The characteristics of the patients at follow-up are shown in Table 5 . Office BP decreased at follow-up with a significant difference for diastolic values (SBP from 146 ± 15 mm Hg at T0 to 142 ± 20 mm Hg at T1, NS, DBP from 88±9 mm Hg at T0 to 83± 11 mm Hg at T1, Po0.05) while 24-h ambulatory BP was unchanged (SBP 125 ± 14 mm Hg at T0 and 126±13 mm Hg at T1, DBP 76±8 mm Hg at T0 and 74 ± 6 mm Hg at T1, Figure 3) . IMT increased at follow-up from 0.14 ± 0.06 to 0.18±0.10 mm (Po0.001). In a logistic regression model including IMT at follow-up as the dependent variable and age, smoking status, cholesterol, diabetes and diastolic BP as independent variables, IMT at T1 was predicted by the presence of diabetes and by diastolic BP levels (Table 6) .
At the end of follow-up, prevalence of cognitive impairment was 52% in the whole sample. Attention was impaired in 13% of the whole sample, executive function in 36% and memory in 26%. Scores of single cognitive tests and composite scores by cognitive domains are shown in Table 7 . We found a significant improvement in attention and executive functions but a worsening of immediate and delayed memory, in spite of no change in Mini-Mental State Examination.
Discussion
This study shows the time course of cognitive changes in a cohort of long-term treated hypertensives, who never met the clinical criteria for dementia. At basal observation, the executive functions, the most affected cognitive domains, correlated with attention and cerebrovascular damage, but not with BP. Attention was positively correlated to BP (that is, the higher BP, the better attention performance). After 6-year follow-up, attention and executive functions improved, in spite of the minor BP changes, memory decline and progression of cerebrovascular damage. These findings suggest that short-term BP lowering negatively affects executive performance through unfavourable effects on attention. During long-term treatment, attention improves, probably because of adaptation of the cerebral circulation to lower BP, and this accounts for improvement also of executive functions, in spite of the similar BP control and greater cerebrovascular damage. Our data confirm the presence of mild cognitive impairment in hypertensive subjects, involving mainly executive functions, 26, 27 and the protective effect of antihypertensive treatment against cerebrovascular damage. 9 Association of IMT to cognitive dysfunction has already been shown in patients with cerebrovascular disease and dementia. 28 Our data extend these observations to undemented patients without stroke.
On the contrary, we found no correlation between BP control and executive functions at enrolment, at variance with others. 7 This apparently contrasting result could be explained by the presence of a confounding variable that is independently related to both cognitive performance and BP, such as attention. The strong positive relationship between attention and BP levels and between attention and executive functions, in our results, suggest that any possible improvement of executive functions by BP lowering is initially masked by decreased attention, which is worsened by low BP. The different effect of BP control on different, mutually dependent, cognitive domains explains the unlinear relationship of BP levels and cognitive functions. 29 Office BP slightly decreased at follow-up in spite of aging of the study cohort, showing effectiveness of antihypertensive treatment and good compliance. Executive functions and attention improved, even if IMT, a predictor of executive function at baseline, increased at follow-up. Long-term antihypertensive therapy is more effective in stabilizing BP levels, compared with short-term treatment, because of gradual dose adjustments, selection of the most appropriate drugs on an individual basis and improvement of compliance. BP variability, risk of hypotension and cerebral hypoperfusion are, thus, minimized. Well-managed, long-term antihypertensive treatment can decrease small vessel alterations and improve cerebrovascular reserve, as it has been shown with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. 30, 31 Microcirculation improvement is not necessarily correlated to IMT and it may be accompanied by progression of macrovascular changes, as suggested by a previous study that showed improvement of focal brain hypoperfusion with long-term antihypertensive therapy, in spite of the progression of carotid artery atherosclerosis. 32 This can happen because macrovascular structural disease is less easily reversed than microvascular changes, which are, at least in part, functional.
Our finding of a positive association of BP levels with attention is consistent with previous evidence that constitutional hypotension is associated with worse performance in attention tests. 33 We hypothesize that attention is dependent on pressure-dependent brain perfusion reserve in long-standing hypertension, because of reduced reactivity of the brain microcirculation due to chronic hypertensive damage. Long-term BP stabilization and improvement of brain haemodynamic improves attention, which, in turn, has a positive effect on executive functions.
Strengths and limitations of our study have to be stressed. Strength of our study include the use of a comprehensive set of cognitive tests to examine different cognitive domains separately and integration of several laboratory indices of cerebrovascular damage, which had been used only separately from neuropsychological data in previous studies. 
Cognitive function in hypertension
Limitations include a small sample size at follow-up because 14 patients could not be re-evaluated at follow-up, but a high drop out rate for severe diseases is common in an elderly sample. The small number did not allow analysis on cognitive effect of single antihypertensive drug classes, because most patients were on a multidrug treatment. The vasoreactivity study was not repeated at follow-up. Therefore, our interpretation of the cognitive outcome as result of improvement of the microcirculation needs confirmation with further studies.
Perspectives
Antihypertensive therapy protects against impairment of executive and attention performance with a different time course. The protective effect is apparent in spite of the BP levels slightly above the recommended BP goals, as stated by practise guidelines, and in spite of the progression of macrovascular atherosclerosis. The mechanisms underlying the effect of hypertension on cognitive function are, thus, different form those underlying hypertensioninduced macrovascular damage and atherosclerosis. All these observations have to be taken into consideration when investigating the relationships between BP and cognitive function.
